10,372
Views
59
CrossRef citations to date
0
Altmetric
Review Articles

Application of some nanoparticles in the field of veterinary medicine

, , &
Pages 78-93 | Received 26 Sep 2019, Accepted 06 Nov 2019, Published online: 26 Dec 2019

ABSTRACT

Nanotechnology is a fast-growing technology that plays an important great impact on various fields of therapeutic applications. It is capable for solving several problems related to animal health and production. There are different nano-systems such as liposomes, metallic nanoparticles, polymeric micelles, polymeric nanospheres, functionalized fullerenes, carbon nanotubes, dendrimers, polymer-coated nanocrystals and nanoshells. In this review, we mentioned different methods for the preparation and characterization of nanoparticles. This review is concerned mainly on nanoparticle systems for antibiotic delivery which suffer from poor bioavailability and many side effects. Nanoparticles are characterized by many features include their minimal size, colossal surface zone to mass extent. The development of antimicrobials in nanoparticle systems is considered an excellent alternative delivery system for antimicrobials for the treatment of microbial diseases by increasing therapeutic effect and overcoming the side effects. In this paper, we reviewed some antimicrobial nanoparticle preparations and we focused on florfenicol and neomycin nanoparticle preparations as well as chitosan and silver nanoparticles preparations to prepare, characterize and compare their different pharmacological effects.

1. Introduction

Nanotechnology is viewed as a quickly developing field that was initially created around 1974 for assembling novel materials ranged from 1 to 100 nm [Citation1Citation4]. Nano is originated from the Latin word nanus, identical to predominate which implies very little size (1nm equals 109 m) [Citation5Citation7]. Nanotechnology is viewed as another innovation that takes an interest in numerous fields including science, agriculture and infection treatment delivery assays [Citation8]. Furthermore, nanomaterials have potential impacts for in-vivo and in-vitro biomedical applications and researches [Citation9,Citation10].

Nanoparticles have inventive physicochemical characteristics superior to the mass material due to their enormous surface to volume proportion, higher reactivity, huge surface to volume, stability, bioactivity, bioavailability, controlled particle size, controlled release of drugs, site-specific targeting and controlled arrival of medications [Citation11Citation17]. Furthermore, nanotechnology has an incredible potential on medication delivery in view of their capacity to enter cells, tissues and organs than macro particles so, conquer poor bio-accessibility and high toxicity of present pharmaceutics [Citation11,Citation18,Citation19]. Medications might be incorporated inside the nanoparticles or connected to their surface [Citation20].

In addition, nanomedicines are portrayed as the utilization of different apparatuses dependent on nanotechnology to widen snappier and additional responses for scientific issues or infection control. It is not handiest in a situation to overcome the difficulties experiencing the customary cure, yet in addition, it allows the comprehension of assorted physiological and obsessive techniques. Profound aptitude for such procedures gives new potential outcomes and remedial norms for effectively current issues [Citation21]. The economy of most nations is reliant on animals. In spite of the rise of numerous illnesses new indicative and helpful tools are created by time to recognize and treat animal sicknesses with the end goal of expanded protein supply for human nourishment [Citation17]. In the field of Veterinary Medicine, nanotechnology has an incredible potential role in the improvement of delivery of the drugs [Citation8]. The curiosity of newly synthetic atoms can provide us a new helpful medicinal drugs with the intention to treat diseases and guard creatures from viral or bacterial diseases and improve wound recuperating. Furthermore, those new mixes could convey drugs into cells for the successful remedy of diseases [Citation21]. Nano-theranostics are considered as a treatment strategy which combine medications with diagnostics, they aim to monitor the treatment response and increase the efficacy and safety of drugs. In addition, they provide a great chance to design and develop such combination agents, allowing the delivery of therapeutics and the detection modality that used before and throughout the treatment regimen [Citation22,Citation23]. Nano pharmaceuticals are a standout amongst the most encouraging and beneficial fields of nanotechnology which has numerous advantages in veterinary medication [Citation24].

2. Classification of nanoparticles

There are numerous classifications of the nanoparticles depending on their origin, shape, structure and aim of administration.

2.1. According to their structure and their use in veterinary medicine

2.2. According to their origin

According to their origin, they are classified into organic, inorganic and hybrid nanoparticles.

2.2.1. Inorganic nanomaterials

Generally, they are save and are typically biocompatible and are less cytotoxic. They have novel electrical and optical characteristics which can be adjusted during assembling. This group includes different inorganic materials, for example, gold, silver, iron oxide and calcium phosphate [Citation50].

2.2.2. Organic nanomaterials

2.2.2.1. Proteins and peptide nanoparticles

They are utilized for the most part in quality delivery measures (e.g. gelatin) because of their low lethality, minimal effort of creation, high biodegradability and bio similarity. They can likewise cooperate with different payloads. There are two sorts of utilized gelatins type A (extracted from tissues by acids) and type B (separated by bases) which vary in their isoelectric focuses [Citation51,Citation52].

The utilization of gelatin B offers an incredible bit of leeway as its isoelectric point is 4.8–5.2, which enables it to interface with positively charged atoms at physiological pH. Gelatin B is contrarily charged; in any case, when it experiences an endosome, it changes its charge and become decidedly charged, with the goal that the emphatically charged burden will be easily discharged inside the phones. For their utilization to convey DNA, the gelatin molecule must be conjugated to an exceptionally positive sub-position (for example, Protamine sulphate) to trap the DNA inside the atom complex [Citation53].

The hereditary material can likewise be conveyed together with helpful operators simultaneously when both are co-stacked in centre shell NPs in which the centre protein is made of egg whites [Citation54].

2.2.3. Hybrid nanoparticles

They are composed of more than one sector of nanoparticle, e.g. mixture of polymeric NP and liposomes that results in a polymer-lipid hybrid system. The formed compound is characterized by a core of biodegradable hydrophobic polymers loaded with hydrophilic drugs for simultaneous release of the drugs. The lipid layer controls the water penetration to the nanoparticles and drug release from them [Citation55,Citation56].

2.3. According to their shape

They are classified into (spheres, tubes or liquid drops), depending on the aim of application (e.g. therapeutic, diagnostic, vaccine administration, nutritional) [Citation56].

2.4. Miscellaneous classification

  1. Immune-invigorating edifices: they are considered as supramolecular saponin adjuvant particles. Their main use is to trap different viral antigens via hydrophobic combination with viral wrap proteins [Citation57,Citation58].

  2. Virus-like particles: Particles of self-collecting property going in size from 20 nm to 800 nm. Due to the lake of the nucleic corrosive, in this manner, they can invigorate strong insusceptible reaction without having the option to actuate contamination [Citation59].

  3. Self-gathering frameworks/proteins: They drive more elevated amounts of protein quaternary structures to be utilized in human and animal vaccination [Citation60].

3. Different methods for preparation & characterization of some nanoparticles

3.1. Different methods for preparation of nanoparticles

3.2. Different methods for nanoparticles characterization

3.2.1. Molecule size of nanoparticles

Particles size influence the medication discharge. Little particles give the bigger surface area. As a final product, the limit of the medication stacked onto them can be revealed to the molecule surface so speed medication discharge [Citation65].

There are several tools for determining nanoparticle size:

3.2.1.1. SEM

Scanning electron microscope is giving a morphological assessment with direct perception. They give bound data about the size dispersion and the normal of genuine populace. This technique is tedious, costly and frequently need reciprocal insights about estimating dispersion [Citation66].

3.2.1.2. TEM

Transmission electron microscope is mainly utilized for recognizable proof of the morphology of the prepared nanoparticles.

3.2.1.3. Atomic force microscopy

2D and 3D AFM images are used to determine surface topography and roughness profiles of nanoparticles.

3.2.1.4. Zeta potential

Used for determine zeta potential value, size of nanoparticles and surface charge [Citation67].

3.2.1.5. Surface hydrophobicity

Determined by numerous techniques along with hydrophobic interplay chromatography, biphasic partitioning and adsorption of probes [Citation68].

3.2.1.6. Drug release

Drug release assays also are just like drug loading assay which is classed to investigate the drug release mechanism [Citation69].

Summary of several tools for determining nanoparticle size:

4. Applications of nanotechnology

Nanotechnology is viewed as an incredible solution for numerous issues especially for health of animals and improvement of their production.

4.1. Possible applications of nanotechnology in medical science

4.2. Uses of nanotechnology in veterinary medicine

Nanotechnology has a significant effect for veterinary prescription in numerous fields incorporates therapeutics, diagnostics, tissue building, immunization generation and disinfectants. The Nano-applications are as of now being used inside the region of creature wellbeing, rearing, proliferation and sustenance of creature. The vehicle of the medicine straightforwardly into the target cells empowers utilizing exceptionally low dosages that progressively diminish the medication build-ups and withdrawal period in homestead animals [Citation56].

4.3. Potential uses of nanotechnology in animal production

A couple of potential uses of nanotechnology in animal production includes; the executives of drug, vitamins, probiotics and nutritional supplements, similarly, using nanoparticles for detection and removal of causes of infection without surgery. However, the normal use of antibiotics in animal production can leave a residue that affects the final consumer whilst even as using nanotechnology reduces the range of antibiotics used because of their Nano size [Citation81].

This was confirmed by Fattal et al. [Citation82] who studied the impact of ampicillin loaded to nanoparticles on mice infected with Salmonella typhimurium, and result confirmed that mice treated ampicillin joined to nanoparticles confirmed higher survival ratio much like ordinary manage group, the distinction becomes because of the earlier required 40 instances less antibiotic to reap the identical impact with a higher distribution in tissues, so tested the lower amount of antibiotic required to present the same effects. Animal production, need to gain from this period thru the usage of nano-fertilizers that deliver vitamins to particular places within the forages, inside the required quantities. This may be completed with the useful resource of magnets. Similarly, nanomaterials may be utilized in combination with hydrogels or zeolites to enhance water excellent with the aid of using soaking up poisonous substances [Citation83].

4.4. Impact of nanotechnology for animal health and nutrition

Nano minerals are inexpensive, utilized in lower quantities, and act as growth-promoting and immune-stimulating agents so, produce many benefits for animal feed production. Similarly, they also can help to manipulate feed pathogens and improve fermentation process in the rumen. Nano zinc oxide is considered one of the promising Nano minerals that used to improve the growth rate, immune response and also disorders affect livestock reproduction. Further diarrhoea in young piglets can be reduced by Nano zinc [Citation84]. Nano zinc decreases the somatic cell count in dairy cows suffered from subclinical mastitis [Citation85].

Microencapsulation of feed components is done in order to protect them from oxidation and break down by light and oxidation, further it keeps them away from the lysis by enzymes of the digestive system such as proteases, also promote stability at various values of pH, with better dispersion and good mixing of lipophilic additives, and will prolong their action. A big problem affecting animals and human is the mycotoxicosis present in about. They may be detected in about 25% in the feed of animals. Nano silica and nano magnesium oxide are considered a powerful nano antimycotoxin that bind successfully to aflatoxins and inactivate them [Citation86].

4.5. Application of nanotechnology in breeding and reproduction

Diagnosis and treatment of reproductive problems, oestrus detection, sperm freezing and the direct calving interference are done by several nanotechnology applications. Further, many reproductive problems like retained placenta can be treated by nanotechnology. In addition, nanoparticles have a great impact in protection and sustaining the release of hormones of reproduction like steroid hormones or gonadotropic hormones [Citation87].

One of the most up to date and powerful apparatus utilized in creature generation is nanotubes they are utilized because of the issue of surprising expense and longer time needed for rearing and proliferation, a nanotube might be established beneath the pores and skin to offer precise time measurement of modifications in oestradiol organize within the blood. Oestrus in animals can be discovered by nanotubes since their ability at the time of oestrus to bind on the oestradiol antibody via fluorescence of infrared. Further, nowadays Micro fluidics facilitates in vitro fertilization processes [Citation88].

Nano sensors are another device with a cell probe. These probes are mainly utilized in diagnoses of genital tract infectious illnesses, metabolic and hormonal issues or may be the detection of oestrus [Citation89].

For animal, sterilization nanoparticles can be used as contraceptives depending on the toxicity of some metallic nanoparticles which includes cadmium whilst given in low doses. Course of metallic nanoparticles to the reproductive tract of the animals increases their impact there [Citation56].

5. Nanotechnology applications in veterinary therapeutics

Nowadays, nanotechnology is supposed to play a promising role in veterinary therapeutics [Citation90]. One example is that the mixture nanocarrier-mediated therapy is effective in treatment of diseases affecting animals producing food for human consumption food [Citation91]. From current reviews, it is far advised that quantum dots (QD) are recommended to be used for in vivo imaging in small animal [Citation92]. In addition, nanotechnology is presently carried out for the treatment of trypanosome. This appeared in the facilitated delivery of diminazene (DMZ) to the target site of action. The porous cationic nanoparticles used stepped forward the potential focused on of trypanosomes. Evaluation of medical parameters after nanoparticle treatment revealed a partial reduction of allergic conditions [Citation93].

5.1. Nano vaccines and nano adjuvants

Nanoparticles are more and more used in the field of Veterinary vaccine production due to their ability to improve immunological responses. In addition, they are able to serve as adjuvant in order to make the antigens slowly released this will increase vaccine performance [Citation94]. The use of nanoparticles for loading of antigens results in targeting the lymph nodes leading to vaccine performance improvement [Citation95].

5.1.1. Examples explain the various types of nano vaccines used in veterinary medicine

A. Examples of nano emulsion vaccines are recombinant B. anthracis spore-based vaccine and influenza vaccine. B. Following oral administration of vaccine loaded on PLGA nanoparticles, they produce Immunoglobulin type G and Immunoglobulin type A immune reaction example of these vaccines are Helicobacter pylori, Tetanus toxoid, Bordetella pertussis vaccine and Bovine para influenza type III vaccine. C. Recombinant Leishmania SOD vaccine is an example of vaccines that loaded on chitosan nanoparticles and given by subcutaneous injection, in addition, TB vaccine loaded on chitosan is given through respiratory tract, also pneumococcal antigen a vaccine and Streptococci equi vaccine are loaded on chitosan and given by intranasal route. Gold nanoparticle-based vaccine is given in opposition to foot and mouth disease. D. Empty capsid and centre like particle vaccines of the virus which affect horse and called African horse sickness [Citation96Citation107].

6. Implementation of nanotechnology in pet animal care

For pet animal care nanotechnology was likewise connected to grow new items. They are used in the improvement of surface freshening up and disinfectants due to their physicochemical properties. For example, silver nanoparticle is incorporated in shampoos for topical use [Citation90].

7. Current limitation and safety of nanoparticles

In general, most nanoparticles are safe, but a few may additionally have risky outcomes such as; extended pulmonary publicity to carbon nanotubes might lead to reproductive problems to the workers of the pharmaceutical organizations [Citation108]. Furthermore, the development of attractive nanoparticles made from iron oxide inside the edge, or through harms expedited because of unsteady authoritative between the medication and the particles that moreover may dispatch the medication in solid tissues rather than the objective tissues. The incomplete arrival of the direction away from its objective tissue or organ will now cause healthy tissue toxicity as well as the conveying of dosages in a sub-therapeutic level at the objective component. Their ability to move various organic restrictions inside the casing, for instance, the blood–brain barrier commits any error has extraordinary outcomes, evenly at the environment, for example, the expanding call for radionuclides, also nano fibres with carbon likewise are implicated to consume the ozone layer in the biological system [Citation21,Citation108Citation110].

8. Application of nanoparticles in drug delivery systems

Nanoparticles in the field of pharmacology are considered an ideal drug delivery system that not only guard animals from viral or bacterial infections but further enhance wound healing and can reduce pain. Additionally, those new compounds deliver drugs to the target tissues and organs. Those frameworks can have an impact at the pace of assimilation, appropriation, digestion and discharge of medications or different substances in the body and permitting the observing of the drug dynamics, acquire a therapeutic effect, ensure bioavailability, stability, lengthen the length of movement, reduce the frequency of doses required to preserve the therapeutic responses and reduce the toxicity [Citation108].

8.1. Classification of nanoparticle delivery systems

From the delivery system perspective nanoparticles are assembled into Polymer-based, lipid-based and metal-based delivery systems:

Polymer-based delivery system such as dendrimers, nanospheres, niosomes and polymeric micelles. Also, it was classified into Natural polymers such as chitosan, collagen, gelatin and engineered polymers like PLA and PLGA. Lipid-bases delivery system such as nanoliposomes, solid lipid nanoparticles and lipid vesicles. Metal-based delivery system such as nanotubes, metal colloids, gold nanoshells and fullerenes [Citation111].

9. Disadvantages of use of the native antimicrobials

The invention of antibiotics inside the twentieth century resulted in reduction of the morbidity and mortality caused by microbial infections. In spite of the great progress with antimicrobials improvement, many infectious diseases, especially intracellular infections, stay difficult to be treated. In continual infections, micro-organisms stay alive from months to years. Insufficient and occasional shipping of antimicrobial agents may also cause inadequate therapeutic index with the improvement of antibiotic resistance, neighbourhood and systemic facet effects like nausea, vomiting, irritation, scaling and gut microflora reduction are taken into consideration terrific problem that encourages the pharmaceutical agencies and researchers to simultaneously increase novel antibacterial capsules and delivery system to overcome multidrug-resistant microorganism [Citation112,Citation113].

10. Favourable circumstances of utilizing nanoparticles as another drug delivery system for antimicrobial therapy

They upgrade remedial viability and symptoms of medications. They improves the dissolvability of inadequately water-solvent medications.

Nanoparticles have distinctive properties such as ultra-little, controllable size, enormous surface zone and high reactivity thus, facilitate administration of antimicrobial medication. They conjointly enhance therapeutic effectiveness and minimize limits undesirable aspects of pharmaceutical compounds. In addition, they potentiate the solubility of less water-soluble drugs. Further, they raise the potency of therapeutic compounds and increase the specificity towards target cell or tissue. They have incredible favourable circumstances such as their ability to Prolong the systemic circulation lifetime of drugs, improve bioavailability, decrease sedate digestion and empower an increasingly controllable arrival of helpful mixes and the conveyance of at least two medications at the same time for mix treatment. They also are used for Renewing of old pharmaceutical bases which were continued used. They are capable to reduce toxicity and collateral effects of conventional pharmaceutical compounds. In addition, they can overcome the hazards of drug residues as they produce low residues in animal products. One of the important advantages of using nanoparticles is the reduction of the needed doses, frequency of dosage and concentration of drug during the course of treatment [Citation114Citation116].

11. Review of some antimicrobial nanoparticles used in veterinary medicine with special consideration to florfenicol and neomycin

Covalent connection of a penicillin polyacrylate nanoparticle with roughly 100 nm was reported to be effective in treatment of MRSA, through protection against action of bacterial β-lactamases [Citation117]. Ceftiofur-loaded PHBV Poly (3-hydroxybutyrate-co-3-hydroxyvalerate) was reported to improve the infectious diseases treatment in the livestock [Citation118]. Oral administration of tilmicosin-loaded lipid nanoparticles in broiler chickens was founded to be have more bioavailability and suggested to be an efficient delivery system for tilmicosin [Citation119]. Streptomycin coated chitosan-magnetic nanoparticles by incorporation method showed fast release profiles, slower as time progressed and have more enhanced antibacterial activity against methicillin-resistant Staphylococcus aureus [Citation120].

11.1. Florfenicol

Florfenicol is a fluorinated analogue of thiamphenicol and considered as an economical broad-spectrum antibiotic which is widely used for prevention and treatment of many against gram-positive and gram-negative bacterial infections [Citation121]. It has been widely used to prevent and treat the respiratory diseases in bovine [Citation122], vibriosis in fish [Citation123] and swine and chicken diseases in the People’s Republic of China since 1999 [Citation124]. Its mechanism of action is similar to that of thiamphenicol and chloramphenicol. Florfenicol overcomes the risk of chloramphenicol-related aplastic anaemia and abolishes the bacterial acetyltransferase-mediated drug resistance due to modified chemical structure [Citation125]. Florfenicol has high efficacy at lower concentrations than its structural analogues against many chloramphenicol-resistant or thiamphenicol-resistant strains [Citation126].

There are some disadvantages of florfenicol, firstly its poor solubility in aqueous solutions [Citation126] so organic solvents are normally utilized in its clinical fluid definitions. The elimination half-time of florfenicol is less than 3 h in some animals [Citation127Citation129]. What is more, frequent dose is required in clinical applications to acquire better helpful efficacies. Administration in a frequent manner would build work cost and creature stress. In this way, advancement of florfenicol novel plans has promising viable qualities.

11.1.1. Review of some florfenicol nanoparticle preparations

The following studies demonstrated different nanoparticle preparations for florfenicol:

11.1.1.1. Study on florfenicol-loaded solid lipid nanoparticle suspension

Preparation was done by hot homogenization and ultrasonic technique. Value of zeta potential was >47 mV. Minimum inhibitory concentration was 6 and 3 μg per mL against S. aureus and E.coli, respectively. Median lethal dose was >5000 mg per kilogram body weight [Citation129].

11.1.1.2. Control release of florfenicol using silica nanoparticles as a carrier

Florfenicol was loaded on silica nanoparticles as a carrier in aqueous solution. Through a natural cooling process from 95°C to room temperature adsorbtion of florfenicol on silica nanoparticles in aqueous solution was obtained. Characterization was done by transmission electron microscope, Zeta sizer laser particle size analyser, FTIR, thermal gravimetric analysis. Results revealed that the adsorption was done without degradation. Florfenicol nanoparticles showed a slower sustained release of florfenicol than the rapid release of native florfenicol [Citation130].

11.2. Neomycin

Broad-spectrum poorly absorbed bactericidal aminoglycoside antibiotic with and indicated for prevention and treatment of bacterial enteritis in poultry occur due to caused by bacteria susceptible to salmonellosis and colibacillosis. Its mode of action is at the ribosomal level. When administered orally, only a fraction (<5%) is absorbed systemically when administrated orally. Neomycin sulphate was effective at 11 or 22 mg per kilogram body weight, when administered in the drinking water for 5 days. Neomycin disadvantages are nephrotoxicity and ototoxicity [Citation131].

11.2.1. Review of some neomycin nanoparticle formulations

Neomycin loaded chitosan nanoparticles was formulated and evaluated and studied for its antimicrobial activity. The prepared formulation showed entrapment efficiency (%EE) of65.5%, scanning electron microscopy round shape and smooth surface. The in-vitro release profile was found to be 96.65% sustained up to 330 min. In addition, the drug release enhanced when compared to pure drug [Citation132].

A comparison of different neomycin nano biocomposites marketed ointment was done for in-vitro and in-vivo evaluations. Authors concluded that the prepared zinc chitosan neomycin nanoparticle (0.2% neomycin) was found to be the best formulation of neomycin containing less than half of the concentration of neomycin of nemozin ointment (0.5%) with low side effects and high efficacy at low doses [Citation133].

Neomycin loaded silver nanoparticle preparation was found to have a synergistic effect in 45% of mastitis-inflicting Staphylococcus aureus in milk samples. Authors proposed that the synergistic impact might be because of drug transport of silver nanoparticle to the cell. It is far well known that hydrophobic groups are discovered in cell membranes. Gentamicin and neomycin are hydrophilic however silver nanoparticles are hydrophobic. For this reason, silver nanoparticle in contrast to antibiotics can easily bypass cellular membrane and reach to the target cell effectively [Citation134].

12. Polymeric nanoparticles with special interest to chitosan

They are classified into two types polymeric nanoparticles natural and synthetic. Examples of natural polymers are chitosan which is one of the natural polymers are inulin and chitosan which are polysaccharide in nature.

12.1. Chitosan nanoparticles

Chitosan is a promising nano-carrier to release the encapsulated drug to the targeted tissues [Citation135].

12.1.1. Preparation of chitosan nanoparticles

There are different methods for synthesis of Based on ionic gelation method of TPP with chitosan [Citation136].

12.1.2. Properties of chitosan nanoparticles

Preparation is done by the interaction of oppositely charged macromolecules [Citation137]. Compared with other biological polymers, chitosan is one of the most extensively used polymers due to biocompatibility, biodegradability and less toxicity. The interaction can be controlled by the charge density of Tripolyphosphate and chitosan. They are considered as ideal drug delivery system for poorly soluble, poorly absorbed substances [Citation138].

12.1.3. Review for antimicrobial activity of chitosan nanoparticle

Ampicillin-loaded chitosan nanoparticles were studied for their antimicrobial activity against Escherichia coli. The study revealed that chitosan nanoparticles capably prolonged the ampicillin delivery due to nanoparticle size and increased surface charge, resulting in inhibition of E. coli growth [Citation139].

A Generation protocol for the synthesis of chitosan nanoparticles loaded with florfenicol through the ionic gelation method was studied. In this way, the synthesis of chitosan nanoparticles loaded with florfenicol could provide advantages when it comes to protecting, transporting and releasing the drug in fish of economic interest in a controlled manner. The results obtained with FTIR spectrometry corroborate the formation of the Q-TPP nanoparticles with the changes observed in the infrared spectra patterns between the matrix chitosan and the synthesized nanoparticles. Q-TPP nanoparticles can carry between 48% and 50% of florfenicol inside. The in vitro release assay of the antibiotic showed a controlled and stable release over time under conditions of acid pH and controlled temperature of 15°C for up to 10 days [Citation140].

13. Metallic nanoparticles

13.1. Silver nanoparticles and their anti-microbial activity

Different methods are involved in synthesis of silver nanoparticles one of them is the precipitation method by using a reducing agent trisodium citrate (TSC) [Citation141].

Silver nanostructures were reported to have a potential effect on gram-positive like S. aureus and gram-negative bacteria Echerichia coli, Klebsiella and Pseudomonas. These nanoparticles act by attacking the respiratory chain and cell division, finally leading to cell death. In addition, the STEM (Scanning Transmission Electron Microscopy) confirms the presence of silver in the cell membrane and inside bacteria [Citation142]. Previous studies demonstrated that silver nanoparticle have many different pathways of bactericidal activity either by the effect of release of free radicals or reactive oxygen species (ROS) in addition the interaction of silver nanoparticles with bacterial cells in the form of connection with the respiratory enzymes or diminishing the intracellular ATP levels may lead to breaking down the cell wall of the bacteria [Citation143,Citation144]. The effects of silver nanoparticles on Staphylococcus aureus contaminated open wounds healing in mice was studied and results showed a remarkable in vivo nano silver accelerating effects on treatment of S. aureus infected skin wounds with no obvious side effects in mice [Citation145].

14. Importance of nanocomposite

Nanocomposites are characterized by High dispersion in aqueous medium, uniform distribution of the active component for a long time, Controlled drug release, Reduction of frequency of administration, improvement of stability, penetrate regions inaccessible to other delivery systems [Citation146,Citation147].

15. Current applications of nanoparticles used in veterinary medicine

15.1. Medical diagnostics

Nanoparticles that used in this sector facilitate diagnosis and prognosis of diseases, availability for small samples and fast analyses of samples. But they have some disadvantages like difficult preparation of sample. Higher Sensitivity of small samples and price [Citation148].

15.2. Biocides

They are alternatives to antibiotics and serve as antimicrobial coatings but they are cytotoxic and applied mainly in vitro [Citation149,Citation150].

16. Future perspective on the use of nanoparticles in veterinary medicine

As nanotechnology keeps on creating and collect more consideration, its applications in the creature generation industry will turn out to be increasingly broad. The customary consideration of nano-enhancements to strengthen animals feed is likely conceivable sooner rather than later; in any case, it will take more time for nanoparticles to completely supplant anti-infection agents in feed. The same number of biocidal competitors should in any case be tried in vivo before experiencing clinical preliminaries and sanitation tests as per government guidelines. For concentrates keen on nanoparticles with hostile to malignancy properties, it is critical to examine nanoparticle cytotoxicity in both disease cell lines and typical, solid cell lines. Just utilizing disease cells and guaranteeing the nano-molecule under scrutiny has hostile to malignancy properties might be deluding, as the nanoparticle might be cytotoxic to all cell types. In vivo examinations are required for verification of nanoparticle capacities seen in vitro research. Nonetheless, the advancement of perfect nanomaterials that are equipped for sending sign to the ailing or harmed cells and tissues to trigger the recovery procedure still stays a test. Also, the wellbeing of creatures as far as the utilization of nanomaterials in regenerative drug involves significant concern, since this field is still in its incipient stage. Employments of veterinary animals are progressively perceived as basic translational models of human illnesses. At long last, to comprehend the hidden components of cell-biomaterial associations at the nanoscale level, and to have the option to decipher the discoveries from seat to bedside, close cooperation between the researchers and veterinary clinicians is of most extreme significance. At long last, progresses in veterinary regenerative prescription could offer significant hotspots for contemplating human illness and furthermore it could offers a setting for dispersal of data about veterinary therapeutics that can quicken translational medication. Besides, the investigations are basic in the creature generation industry and especially to recognize the holes among learning and applications [Citation151].

16.1. Examples of future applications of nanoparticles used in veterinary medicine

16.1.1. Nutraceuticals

Nanoparticles used in this sector have many advantages such as; higher bioavailability of nutrients, enhancement of growth rate and performance, the most common limitation is the degradation within the gastrointestinal tract [Citation151,Citation152].

16.1.2. Drug delivery systems

Used for enhancement of drug specificity and delivery. They diminish MIC and have a bactericidal effect on antibiotic-resistant strains of pathogens. Disadvantage is less biocompatibility [Citation153,Citation154].

16.1.3. Sperm nanopurification

Depending on biomarkers selection and isolation of desired healthy sperm is performed. Nanoparticles used in this sector potentiate fertilization efficiency that facilitates fertilization of more females from a single collection. It had some limitation such as; to be developed it needs biomarker library and restrictions of purebred on artificial insemination [Citation155].

17. Conclusion

In this paper, we reviewed different types of nanoparticles and different methods for their preparation and characterization, in addition, we reviewed the role of nanosystem in drug delivery of antimicrobials used in Veterinary Medicine with special consideration to silver and chitosan. Our willing study will be proposed to increase the efficacy of the selected antibiotics against pathogenic strains of bacteria, overcome the antibiotic resistance, decrease the toxicity and improve the bioavailability of selected antibiotic. The suggested protocol of the study is preparation of selected antibiotics loaded chitosan and silver nanoparticles characterization by this methods (XRD, Raman, FTIR, AFM, TEM, SEM, zeta seize and potential) and performing in-vitro studies including comparative efficacy of the tested drug and the prepared nanoparticles against standard, sensitive and resistant strains of micro-organism using different techniques as (sensitivity and MIC). According to the results of in-vitro studies, we will do the in-vivo studies which includes; comparative efficacy study of the tested drugs and the prepared nanoparticles in infected animals such as: Pasteurella infection in rabbit, E-coli infection in mice, infected wound in rat, comparative pharmacokinetic studies, comparative safety and toxicity studies of the tested drugs and the prepared nanoparticles using animal model. Investigation of anti-inflammatory effect of the tested nano drug after adding chitosan as it is known to possess anti-inflammatory activity.

Disclosure statement

No potential conflict of interest was reported by the authors.

References

  • Lang L, Ping J, Ming C, et al. 5-Fluorouracil-loaded self assembled pH-sensitive nanoparticles as novel drug carrier for treatment of malignant tumors. Chin J Chem Engg. 2006;14:377–382.
  • Savithramma N, Lingarao M, Suvarnalatha P, et al. Evaluation of antibacterial efficacy of biologically synthesized silver nanoparticles using stem barks of boswellia ovalifoliolata Bal and henry and shorea tumbuggaia roxb. J Biol Sci. 2011;11:39–45.
  • Elgadir MA, Uddin MS, Ferdosh S, et al. Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review. J Food Drug Anal. 2015;23:619–629.
  • Sailor MJ, Park JH. Hybrid nanoparticles for detection and treatment of cancer. Adv Mater. 2012;24:3779–3802.
  • Suzuki Y, Tanihara M, Nishimura Y, et al. A new drug delivery system with controlled release of antibiotic only in the presence of infection. J Biomed Mater Res. 1998;42:112–116.
  • Simi, CK, Abraham TE. Hydrophobic grafted and cross linked starch nanoparticles for drug delivery. Bioprocess Biosyst Eng. 2007;30:173–180.
  • Boulaiz H, Alvarez PJ, Ramirez A, et al. Nanomedicine application areas and development prospects. Int J Mol Sci. 2011;12:3303–3321.
  • Scott NR. Nanoscience in veterinary medicine. Vet Res Comm. 2007;31:139–144.
  • Singh M, Singh S, Prasada S, et al. Nanotechnology in medicine and antibacterial effect of silver nanoparticles. Dig J Nanomater Biostrct. 2008;3:115–122.
  • Troncarelli MZ, Brandão HM, Gern, JC, et al. Nanotechnology and antimicrobials in veterinary medicine microbial pathogens and strategies for combating them: science, technology and education (A. Méndez-Vilas, Ed.). FORMATEX. 2013;1:543–556.
  • Mohanraj VJ, Chen Y. Nanoparticles - A review. Trop J Pharma. 2006;5:561–573.
  • Linko P, Artemye M, Efimo AE, et al. Comparative advantages and limitations of the basic metrology methods applied to the characterization of nanomaterials. Nanoscale. 2013;5:8781–8798.
  • Moudgil BS, Ying JY. Calcium doped organosilicate nanoparticles nanoparticles as gene delivery vehicles for bone cells. Sci Technoladvan Mat. 2007;19:3130–3135.
  • Buzea C, Pacheco BI, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2:1–103.
  • Jin MX, Hu QH. Characterization and application in bioadhesive drug delivery system of chitosan. Central South Pharm. 2008;3:324–327.
  • Zadeh JB, MoradiKor N. Nanotechnology applications in veterinary science. Onl J Vet Res. 2013;17:419–425.
  • Num SM, Useh NM. Nanotechnology applications in veterinary diagnostics and therapeutics. Sokoto J Vet Sci. 2013;11:10–14.
  • Mohsen J, Zahra B. Protein nanoparticle a unique system as drug delivery vehicles. Afric J Biotech. 2008;7:4926–4934.
  • Underwood C, van Eps AW. Nanomedicine and veterinary science: the reality and the practicality. Vet J. 2012;193:12–23.
  • Hahens WI, Oomen AG, deJong WH, et al. What do we (need to) know about the kinetic properties of nanoparticles in the body? Reg Tox Pharm. 2007;49:217–229.
  • Mohantya N, Palaib T, Prustyc B, et al. An overview of nanomedicine in veterinary science. Vet Res. 2014;2:90–95.
  • Chapman S, Dobrovolskaia M, Farahani K, et al. Nanoparticles for cancer imaging: the good, the bad, and the promise. Nano Today. 2013;8:454–460.
  • Rizzo LY, Theek B, Storm G, et al. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr Opin Bio Technol. 2013;24:1159–1166.
  • Feneque J. Nanotechnology: a new challenge for veterinary medicine. Pet Tribune. 2000;6:16.
  • Torres-Sangiao E, Holban AM, Gestal MC. Advanced nanobiomaterials: vaccines, diagnosis and treatment of infectious diseases. Molecules. 2016;21:867.
  • Riley MK, Vermerris W. Recent advances in nanomaterials for gene delivery a review. Nanomaterials. 2017;7:94.
  • Thulasi A, Rajendran D, Jash S, et al. Nanobiotechnology in animal nutrition. Vol. 17. New Delhi: Satish Serial Publishing House; 2013. p. 499–515.
  • Elgqvist J. Nanoparticles as theranostic vehicles in experimental and clinical applications—focus on prostate and breast cancer. Int J Mol Sci. 2017;18:1102.
  • Woudenberg IA, Schiffelers RM, Storm G, et al. Long-circulating sterically stabilized liposomes in the treatment of infections. Methods Enzymol. 2005;391:228–260.
  • Jurj A, Braicu C, Pop L-A, et al. The new era of nanotechnology, an alternative to change cancer treatment. Drug Des Devel Ther. 2017;11:2871–2890.
  • Meena N, Sahni Y, Thakur D, et al. Applications of nanotechnology in veterinary therapeutics. J Entomol Zool. 2018;6:167–175.
  • Freitas RA Jr. Microbivores artificial mechanical phagocytes using digest and discharge protocol. J Evol Technol. 2005;14:1–52.
  • Patil S, Kore K, Kumar P. Nanotechnology and its applications in veterinary and animal science. Vet World. 2009;2:475–477.
  • Rodríguez-Burneo N, Busquets MA, Estelrich J. Magnetic nanoemulsions: comparison between nanoemulsions formed by ultrasonication and by spontaneous emulsification. Nanomaterials. 2017;7:190.
  • Awate S, Babiuk LAB, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013;4:114.
  • Chakravarthi VP, Balaji SN. Applications of nanotechnology in veterinary medicine. Vet World. 2010;3:477–480.
  • Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst. 2007;99:1095–1106.
  • Kudela D, Smith SA, May-Masnou A, et al. Clotting activity of polyphosphate-functionalized silica nanoparticles. Angew Chem Int Ed. 2015;54:4018–4022.
  • Anton N, Vandamme TF. Nano-emulsions and micro-emulsions: clarifications of the critical differences. Pharm Res. 2011;28:978–985.
  • Kang BK, Chon SK, Kim SH, et al. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int J Pharm. 2004;286:147–156.
  • Mcmillan J, Batrakova E, Gendelman HE. Cell delivery of therapeutic nanoparticles. Prog Mol Biol Transl Sci. 2011;104:563–601.
  • Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev. 2012;41:2545–2561.
  • Mieszawska AJ, Mulder WJ, Fayad ZA, et al. Multifunctional gold nanoparticles for diagnosis and therapy of dis-ease. Mol Pharm. 2013;10:831–847.
  • Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine. 2010;6:9–24.
  • Samaya RK, Suraj KG. Nanotherapeutics in cancer prevention, diagnosis and treatment. In Pharmacology and Therapeutics, Sivakumar Joghi Thatha Gowder, Chapter 8, the world’s leading publisher of Open Access books Built by scientists, for scientists. Intech Open; 2014:2–27 DOI:10.5772/58419.
  • Landers JJ, Cao Z, Lee I, et al. Prevention of influenza pneumonitis by sialic acid–conjugated dendritic polymers. J Infect Dis. 2002;186:1222–1230.
  • Fakhri A, Tahami S, Naji M. Synthesis and characterization of core-shell bimetallic nanoparticles for synergistic antimicrobial effect studies in combination with doxycycline on burn specific pathogens. J Photochem Photobiol B Biol. 2002;169:21–26.
  • Mittal AK, Kumar S, Banerjee UC. Quercetin and gallic acid mediated synthesis of bimetallic (silver and selenium) nanoparticles and their antitumor and antimicrobial potential. J Colloid Interface Sci. 2002;431:194–199.
  • Alshatwi AA, Athinarayanan J, Periasamy VS. Green synthesis of bimetallic Au@ Pt nanostructures and their application for proliferation inhibition and apoptosis induction in human cervical cancer cell. J Mater Sci Mater Med. 2015;26:148.
  • Erathodiyil N, Ying JY. Functionalization of inorganic nanoparticles for bioimaging applications. Acc Chem Res. 2011;44:925–935.
  • Jahanshahi M, Babaei Z. Protein nanoparticle: a unique system as drug delivery vehicles. Afr J Biotechnol. 2008;7:4926–4934.
  • Zaboli K, Aliarabi H, Bahari AA, et al. Role of dietary nano zinc oxide on growth performance and blood levels of mineral: a study on in Iranian Angora (Markhoz) goat kids. Int J Pharm Res H Sci. 2013;2:19–26.
  • Lee SJ, Yhee JY, Kim SH, et al. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice. J Control Release. 2013;172:358–366.
  • Karimi M, Avci P, Mobasseri R, et al. The novel albumin–chitosan core–shell nanoparticles for gene de-livery: preparation, optimization and cell uptake investigation. J Nanopart Res. 2013;15:1651.
  • Prabhu RH, Patravale VB, Joshi MD. Polymeric nanoparticles for targeted treatment in oncology: current insights. Int J Nanomedicine. 2015;10:1001.
  • El-Sayed A, Kamel M. Advanced applications of nanotechnology in veterinary medicine. Environ Sci Pollut Res. 2018;10:1–14.
  • Grgacic EV, Anderson DA. Virus-like particles: passport to im-mune recognition. Methods. 2006;40:60–65.
  • Noad R, Roy P. Virus-like particles as immunogens. Trends Microbiol. 2003;11:438–444.
  • Pushko P, Pumpens P, Grens E. Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures. Intervirology. 2013;56:141–165.
  • Kanekiyo M, Wei C-J, Yassine HM, et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature. 2013;499:102–106.
  • Jaiswal J, Gupta SK, Kreuter J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification solvent evaporation process. J Control Release. 2004;96:169–178.
  • Vandervoort J, Ludwig A. Biodegradable stabilizers in the preparation of PLGA nano particles: a factorial design study. Int J Pharm. 2002;238:77–92.
  • Catarina PR, Ronald JN, Antonio JR. Nano capsulation 1. Method of preparation of drug – loaded polymeric nanoparticles. Nano Technol Biol Medicine. 2006;2:8–21.
  • Vargas A, Pegaz B, Devefve E, et al. Improved photodynamic activity of porphyrin loaded into nano particles: an in vivo evaluation using chick embryos. Int J Pharm. 2004;286:131–145.
  • Redhead HM, Davis SS, Illum LJ. Control release drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitrocharacterisation and in vivo evaluation. J Control Release. 2001;70:353.
  • Jores K, Mehnert W, Drecusler M, et al. Investigation on the stricter of solid lipid nanoparticles and oil-loaded solid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 2004;17:217–227.
  • Pangi Z, Beletsi A, Evangelatos K. PEGylated nanoparticles for biological and pharmaceutical application. Adv Drug Del Rev. 2003;24:403–419.
  • Scholes PD, Coombes AG, Illum L, et al. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J Control Release. 1999;59:261–278.
  • Magenhein B, Levy MY, Benita S. A new in vitro technique for the evaluation of drug release profile from colloidal carriers ultrafiltration technique at low pressure. Int J Pharm. 1993;94:115–123.
  • Zhao L, Seth A, Wibowo N, et al. Nanoparticle vaccines. Vaccine. 2014;32:327–337.
  • Jain SK, Sahni Y, Neetu R, et al. Nanotoxicology: an emerging discipline. Vet World. 2011;4:35–40.
  • Venkatesan J, S-K K. Nano-hydroxyapatite composite biomaterials for bone tissue engineering—a review. J Biomed Nanotechnol. 2011;10:3124–3140.
  • Swain PS, Rajendran D, Rao SB, et al. Preparation and effects of nano mineral particle feeding in livestock: a review. Vet World. 2015;8:888–891.
  • Schneider M, Stracke F, Hansen S, et al. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol. 2009;1:197–206.
  • Scott NR. Nanotechnology and animal health. Revue Scien fique Technique (Int Off Epizoocs). 2005;24:425–432.
  • Talukdar D, Sharma R, Sharma KA, et al. Drug resistance in tuberculosis: how to counter the menace? Curr Pharm Biotechnol. 2014;15:1158–1165.
  • Dian L, Yang Z, Li F, et al. Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study. Int J Nanomed. 2014;8:845–854.
  • Chen Y-S, Hung Y-C, Lin W-H, et al. Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide. Nanotechnology. 2010;21:195101.
  • Reis CP, Neufeld RJ, Ribeiro AJ, et al. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine. 2006;2:8–21.
  • Soppimath KS, Aminabhavi TM, Dave AM, et al. Stimulus-responsive Bsmart^ hydrogels as novel drug deliv-ery systems. Drug Dev Ind Pharm. 2002;28:957–974.
  • Dong X, Mattingly CA, Tseng MT, et al. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Res. 2009;69:3918–3926.
  • Fattal E, Youssef M, Couvreur P, et al. Treatment of experimental salmonellosis in mice with ampiciline-bound nanoparticles. Antimicrob Agents Chemother. 1989;33:1540–1543.
  • Lal R. Soil science and the carbon civilization. Soli Sci Soc Am J. 2007;71:1425–1437.
  • Yang Z, Sun L. Effects of nanometer ZnO on growth performance of early weaned piglets. J Shanxi Agric Sci. 2006;3:577–588.
  • Rajendran D. Application of nano minerals in animal production system. Res J Biotechnol. 2013;8:1–3.
  • Moghaddam SH, Jebali A, Daliri K. The use of MgO-Sio2 nano-composite for adsorption of aflatoxin in wheat flour samples. Nanocon. 2010;10:12–14.
  • A Joanitti G, P Silva L. The emerging potential of by-products as platforms for drug delivery systems. Curr Drug Targets. 2014;15:478–485. DOI:10.2174/13894501113149990
  • O’Connell MJ, Bachilo SM, Huffaman CB, et al. Band gap fluorescence from individual singlewalled carbon nanotubes. Science. 2014;297:593–596.planning.
  • Saragusty J, Arav A. Current progress in oocyte and embryo cryo-preservation by slow freezing and vitrification. Reproduction. 2009;141:1–19.
  • Feneque J. Brief introduction to the veterinary applications of nanotechnology. Nanotechnol No wwwwnanotech-nowcom/Jose-Feneque/Veterinary -applications- Nanotechnologyhtm. 2012;7:12–15.
  • Klier J, Fuchs S, May A, et al. A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses. Pharm Res. 2012;29:1650–1657.
  • Bentolila LA, Ebenstein Y, Weiss S. Quantum dots for in vivo small-animal imaging. J Nucl Med. 2009;50:493–496.
  • Kroubi M, Daulouede S, Karembe H, et al. Development of a nanoparticulate formulation of diminazene to treat African trypanosomiasis. Nanotechnology. 2010;21:1–8.
  • Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010;363:2434–2443.
  • Moyer TJ, Zmolek AC, Irvine DJ. Beyond antigens and adjuvants formulating future vaccines. J Clin Invest. 2010;126:799–808.
  • Bielinska AU, Janczak KW, Landers JJ, et al. mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vac-cine protects against Bacillus anthracis spore challenge. Infect Immun. 2007;75:4020–4029.
  • Conway MA, Madrigal-Estebas L, McClean S, et al. Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biode-gradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells. Vaccine. 2007;19:1940–1950.
  • Danesh-Bahreini MA, Shokri J, Samiei A, et al. Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunoge-nicity in BALB/c mice. Int J Nanomedicine. 2011;6:835.
  • Fernando GJ, Chen X, Prow TW, et al. Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. PLoS One. 2010;5:e10266.
  • Florindo H, Pandit S, Lacerda L, et al. The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-ɛ-caprolactone-based nanoparticles. Biomaterials. 2009;30:879–891.
  • Greenwood DL, Dynon K, Kalkanidis M, et al. Vaccination against foot-and-mouth dis-ease virus using peptides conjugated to nano-beads. Vaccine. 2008;26:2706–2713.
  • Hamouda T, Sutcliffe JA, Ciotti S, et al. Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant. Clin Vaccine Immunol. 2011;18:1167–1175.
  • Jung T, Kamm W, Breitenbach A, et al. Tetanus toxoid loaded nanoparticles from sulfobutylated poly (vinyl alcohol)-graft-poly (lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm Res. 2001;18:352–360.
  • Maree S, Maree FF, Putterill JF, et al. Synthesis of empty African horse sickness virus particles. Virus Res. 2016;213:184–194.
  • Okamoto S, Matsuura M, Akagi T, et al. Poly (γ-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Vaccine. 2009;27:5896–5905.
  • Read RC, Naylor SC, Potter CW, et al. Effective nasal influenza vaccine delivery using chitosan. Vaccine. 2005;23:4367–4374.
  • Vila A, Sanchez A, Evora C, et al. PEG-PLA nanoparticles as carriers for nasal vaccine delivery. J Aerosol Med. 2004;17:174–185.
  • Johansson HKL, Hansen JS, Elfving B, et al. Airway exposure to multi-walled carbon nanotubes disrupts the female reproductive cycle without affecting pregnancy outcomes in mice. Part Fibre Toxicol. 2017;30(14):17.
  • Manuja A, Kumar B, Singh RK. Nanotechnology developments: opportunities for animal health and production. Nanotechnol Dev. 2012;2:4.
  • Wu T-J, Chiu H-Y, Yu J, et al. Nanotechnologies for early diagnosis, in situ disease monitoring, and prevention. In: Uskoković V, Uskoković DP, editors. Nanotechnologies in preventive and regenerative medi-cine. Chapter 1. Amsterdam: Elsevier; 2018. p. 1–92.
  • Hill EK, Li J. Current and future prospects for nanotechnology in animal production. J Anim Sci Biotechnol. 2017;8:26.
  • Zhu X, Radovic-Moreno A, Wu J, et al. Nanomedicine in the management of microbial infection – overview and perspectives. Nano Today. 2014;9:478–498.
  • Patel S, Singh D, Srivastava S, et al. Nanoparticles as a platform for antimicrobial drug delivery. Adv Pharma Pharmacy. 2017;5:31–43.
  • Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751–760.
  • Zhang L, Gu FX, Chan JM, et al. Nanoparticles in medicine: therapeutic applications and developments. Clin.Pharmacol.Ther. 2008;83:761–769.
  • Gao W, Thamphiwatana S, Angsantikul P, et al. Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014;6:532–547.
  • Turos E, Reddy GSK, Greenhalgh K, et al. Penicillin-bound polyacrylate nanoparticles: restoring the activity of b-lactam antibiotics against MRSA. Bioorg Med Chem Lett. 2007;17:3468–3472.
  • Vilos C, Constandil L, Herrera N, et al. Ceftiofur-loaded PHBV microparticles A potential formulation for a long-acting antibiotic to treat animal infections Electron. J Biotechnol. 2012;15:4.
  • Rassouli A, Al-Qushawi A, Atyab F, et al. Pharmacokinetics and bioavailability of three promising tilmicosin-loaded lipid nanoparticles in comparison with tilmicosin phosphate following oral administration in broiler chickens. Turk J Vet Anim Sci. 2012;40:540–547.
  • Al-Ali HS, El Zowalaty ME, Hussein M, et al. Synthesis, characterization, controlled release, and antibacterial studies of a novel streptomycin chitosan magnetic nanoantibiotic. Int J Nanomedicine. 2014;9:549–557.
  • Tao X, Yu X, Zhang D, et al. Development of a rapid chemiluminescent CiELISA for simultaneous determination of florfenicol and its metabolite florfenicol amine in animal meat products. J Sci Food Agric. 2014;94:301–307.
  • Shin SJ, Kang SG, Nabin R, et al. Evaluation of the antimicrobial activity of florfenicol against bacteria isolated from bovine and porcine respiratory disease. Vet Microbiol. 2005;106:73–77.
  • Samuelsen OB, Bergh O. efficacy of orally administered florfenicol and oxolinic acid for the treatment of vibriosis in cod (Gadusmorhua). Aquaculture. 2004;235:27–35.
  • Miranda CD, Rojas R. occurrence of florfenicol resistance in bacteria associated with two Chilean salmon farms with different history of antibacterial usage. Aquaculture. 2007;266:39–46.
  • Jiang HX, Zeng ZL, Chen ZL, et al. Pharmacokinetics of florfenicol in pigs following intravenous, intramuscular or oral administration and the effects of feed intake on oral dosing. J Vet PharmacolTher. 2006;29:153–156.
  • Anadon A, Martinez MA, Martinez M, et al. Plasma and tissue depletion of florfenicol and florfenicol-amine in chickens. J Agric Food Chem. 2008;56:11049–11056.
  • Ali BH, Al-Qarawi AA, Hashaad M. Comparative plasma pharmacokinetics and tolerance of florfenicol following intramuscular and intravenous administration to camels, sheep and goats. Vet Res Commun. 2003;27:475–483.
  • Shen J, Hu D, Wu X, et al. Bioavailability and pharmacokinetics of florfenicol in broiler chickens. J Vet PharmacolTher. 2003;26:337–341.
  • Mengmeng L, Wang T, Li X, et al. Preparation, characterisation and antibacterial activity of a florfenicol-loaded solid lipid nanoparticle suspension. IET Nanobiotechnol. 2015;9:355–361.
  • Song M, Li Y, Ning A, et al. Silica nanoparticles as a carrier in the controlled release of florfenicol. J Drug Del Sci Tech. 2010;20:349–352.
  • Marrett LE, Robb EJ, Frank RK. Efficacy of neomycin sulfate water medication on the control of mortality associated with colibacillosis in growing Turkeys. Poult Sci. 2000;79:12–17.
  • Supriya A, Sundaraseelan J, Srinivas BR, et al. Formulation and invitro characterization of neomycin loaded chitosan nanoparticles. Acta Scientific Pharma Sci. 2018;2:34–40.
  • Swathi V, Vidyavathi M, Prasad T, et al. Comparison of different nano biocomposites of neomycin with marketed ointment by in-vitro and in-vivo evaluations. Int J D Del. 2013;5:438–448.
  • Jamaran S, Zarif BR. synergistic effect of silver nanoparticles with neomycin or gentamicin antibiotics on mastitis-causing staphylococcus aureus. Open J Ecol. 2016;6:452–459.
  • Berger J, Reist M, Mayer JM, et al. Structure and interactions in covalently and ionically crosslinked Chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm. 2004;57:19–34.
  • Kunjachan S, Jose S, Lammers T. Understanding the mechanism of ionic gelation for synthesis of chitosan nanoparticles using qualitative techniques. Asian J Pharm. 2014;4:72-76IP: 122.168.132.82.
  • Cho SW, Lee JS, Choi SH. Enhanced oral bioavailability of poorly absorbed drugs. I. Screening of absorption carrier for the ceftriaxone complex. J Pharm Sci. 2004;93:612–620.
  • Shanmugarathinam A, Puratchikody A. formulation and characterisation of ritonavir loaded ethylcellulose buoyant microspheres. J Pharm Sci Res. 2014;8:274–277.
  • Porras-Gómez M, Vega-Baudrit J, Núñez-Corrales S. Ampicillin-loaded chitosan nanoparticles for in vitro antimicrobial screening on escherichia coli. Myriad Functionalities Sci Technol. 2018. DOI:10.5772/intechopen.76034
  • Carmona RE, Plaza T, Recio-Sánchez G, et al. Generation of a protocol for the synthesis of chitosan nanoparticles loaded with florfenicol through the ionic gelation method. Rev Inv Vet Perú. 2018;29:1195–1202.
  • Sedaghat S, Nasseri A. Synthesis and stabilization of Ag nanoparticles on a polyamide (nylon 6, 6) surface and its antibacterial effects. Tehran, I.R. Iran. Int Nano Lett. 2011;1:22.
  • KIM JS, EUNYEKU K, NAMYU K, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007;3:95–101.
  • Deng H, McShan D, Zhang Y, et al. Mechanistic study of the synergistic antibacterial activity of combined silver nanoparticles and common antibiotics. Environ Sci Technol. 2016;50:8840–8848.
  • Adibhesami M, Ahmadi M, Farshid AA, et al. Effects of silver nanoparticles on Staphylococcus aureus contaminated open wounds healing in mice: an experimental study. Vet Res Forum. 2017;8: 23–28. Journal Homepage: vrf.iranjournals.ir.
  • Rauwel P, Rauwel E, Ferdov S, Singh PM. Silver nanoparticles: synthesis, properties, and applications Hindawi Publishing Corporation. Adv Mater Sci Eng. 2015. Article ID 624394. DOI:10.1155/2015/624394.
  • Goodson JM, Holborow D, Dunn RL, et al. Monolithic tetracycline-containing fibres for controlled delivery to periodontal pockets. J Periodontol. 1983;54:575–579.
  • Kapoor D, Vyas RB, Lad C, et al. Role of nanocomposites in drug delivery – a review. Int J Nanotech Nanosci. 2015;3:10–15.
  • Tian T, Li J, Song Y, et al. Distance-based microfluidic quantitative detection methods for point-of-care testing. RSC Adv. 2016. DOI:10.1039/c5lc01562f
  • Hu S, Hsieh Y. Synthesis of surface bound silver nanoparticles on cellulose fibers using lignin as multi-functional agent. Carbohydr Polym. 2015;131:134–141.
  • Napavichayanun S, Amornsudthiwat P, Pienpinijtham P, et al. Interaction and effectiveness of antimicrobials along with healing-promoting agents in a novel biocellulose wound dressing. Mater Sci Eng C. 2015;55:95–104.
  • Sirirat N, Lu JJ, Hung ATY, et al. Effect of different levels of nanoparticles chromium picolinate supplementation on performance, egg quality, mineral retention, and tissues minerals accumulation in layer chickens. J Agric Sci. 2013;5:150–159.
  • Lee YK, Ahn SI, Chang YH, et al. Physiochemical and sensory properties of milk supplemented with dispersible nanopowdered oyster shell during storage. J Dairy Sci. 2015;98:5841–5849.
  • Feng Y, Li D, Wang Q, et al. A carbazole based mitochondria-targeted two-photon fluorescent probe for gold ions and its application in living cell imaging. Sensor Actuat B-Chem. 2016;225:572–578.
  • Li J, Yao P. Self-assembly of ibuprofen and bovine serum albumin-dextran conjugates leading to effective loading of the drug. Langmuir. 2016;25:6385–6391.
  • Pawar K, Kaul G. Toxicity of titanium oxide nanoparticles causes functionality and DNA damage in buffalo (Bubalus bubalis) sperm in vitro. Toxicol Ind Health. 2012. DOI:10.177/0748233712462475